###begin article-title 0
HOXA3 Modulates Injury-Induced Mobilization and Recruitment of Bone Marrow-Derived Cells
###end article-title 0
###begin p 1
Author contributions: K.A.M.: conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, final approval of manuscript; T.E.R.: collection and/or assembly of data, final approval of manuscript; J.L.R.: collection and/or assembly of data, data analysis and interpretation, final approval of manuscript; A.C.P. and H.Y.C.: data analysis and interpretation, final approval of manuscript; D.M.Y.: financial support, data analysis and interpretation, final approval of manuscript; N.J.B.: conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript.
###end p 1
###begin p 2
###xml 27 30 27 30 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tem</sc>
###xml 32 36 32 36 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ells</sc>
###xml 37 43 37 43 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xpress</sc>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E<sc>xpress</sc></italic>
First published online in Stem CellsExpress April 9, 2009; available online without subscription through the open access option.
###end p 2
###begin p 3
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 522 527 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 956 961 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
The regulated recruitment and differentiation of multipotent bone marrow-derived cells (BMDCs) to sites of injury are critical for efficient wound healing. Previously we demonstrated that sustained expression of HOXA3 both accelerated wound healing and promoted angiogenesis in diabetic mice. In this study, we have used green fluorescent protein-positive bone marrow chimeras to investigate the effect of HOXA3 expression on recruitment of BMDCs to wounds. We hypothesized that the enhanced neovascularization induced by HOXA3 is due to enhanced mobilization, recruitment, and/or differentiation of BMDCs. Here we show that diabetic mice treated with HOXA3 displayed a significant increase in both mobilization and recruitment of endothelial progenitor cells compared with control mice. Importantly, we also found that HOXA3-treated mice had significantly fewer inflammatory cells recruited to the wound compared with control mice. Microarray analyses of HOXA3-treated wounds revealed that indeed HOXA3 locally increased expression of genes that selectively promote stem/progenitor cell mobilization and recruitment while also suppressing expression of numerous members of the proinflammatory nuclear factor kappaB pathway, including myeloid differentiation primary response gene 88 and toll-interacting protein. Thus HOXA3 accelerates wound repair by mobilizing endothelial progenitor cells and attenuating the excessive inflammatory response of chronic wounds.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 826 837 826 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif-1&#945;,</italic>
###xml 837 857 833 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa3, Cxcl12/Cxcr4,</italic>
###xml 862 873 858 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vegf/Vegfr2</italic>
###xml 945 946 941 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 947 948 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
Tissue repair and regeneration require dramatic and coordinated changes in cell behavior in both wound-resident cells at the site of injury and in distant cells that respond to and are recruited to the injured tissue. Cells within the skin, normally homeostatic, respond to injury by increasing expression of genes that induce mitosis, migration, and direct synthesis and remodeling the extracellular matrix. This tightly regulated process involves a "ramping up" of growth factor and cytokine release followed by adult stem/progenitor cell mobilization, migration, engraftment, and finally, differentiation in response to injury. Studies investigating the genes involved in this process have identified both transcription factors and ligand/receptor pairs that have previously been implicated in wound healing. Genes such as Hif-1alpha,Hoxa3, Cxcl12/Cxcr4, and Vegf/Vegfr2 among others play a variety of roles in wound repair and regeneration [1-5]; however, much of the genetic control of adult stem and progenitor cell behavior during wound repair and regeneration is largely unknown.
###end p 5
###begin p 6
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 578 591 578 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plaur, Mmp14,</italic>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdc42,</italic>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
Angiogenesis is the growth of new blood vessels from existing blood vessels, whereas vasculogenesis is the growth of new blood vessels from stem or progenitor cells that are presumably recruited from the bone marrow. Previously we demonstrated that the transcription factor, HOXA3, significantly promotes angiogenesis/vasculogenesis during tissue repair and regeneration and accelerates cutaneous wound healing in vivo [3]. In particular we demonstrated that transient gene transfer of HOXA3 to skin wounds of diabetic mice resulted in the upregulation of target genes, such as Plaur, Mmp14, and Cdc42, that are involved in extracellular matrix remodeling and cell migration.
###end p 6
###begin p 7
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
A number of recent studies have also suggested that recruitment of bone marrow-derived cells (BMDCs) can enhance tissue repair in ischemic and myocardial infarction models, as well as in cutaneous wounds (recently reviewed in Wu et al [6]). Both angiogenesis and vasculogenesis can be improved in response to the presence of BMDCs in the wound milieu (recently reviewed in Schatteman et al [7]). Specifically, recruitment of multipotent mesenchymal stromal cells (MSCs) and endothelial progenitor cells (EPCs) can dramatically enhance neovascularization, either through direct incorporation and differentiation in the neovasculature, or by functioning as perivascular support cells that produce additional factors that stimulate repair [8-10].
###end p 7
###begin p 8
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
BMDCs are first mobilized from the bone marrow and enter circulation in response to signals from the wound. Growth factors and cytokines such as VEGF and SDF-1/CXCL12 have been strongly implicated as signals that mediate this response [5, 11]. However, BMDCs consist of a heterogeneous population that can play repressive as well as supportive roles during wound healing. Over the past few decades, studies on the effects of inflammation during wound repair overwhelmingly support a model in which too many inflammatory cells and/or their overstimulation can impede the healing process [12-14]. Although mild inflammation early in response to injury may enhance angiogenesis/vasculogenesis, prolonged and/or excessive presence of leukocytes, activated neutrophils, and macrophages in particular, are associated with chronic wounds that have severely impaired healing [15, 16], and may interfere with efficient neovascularization.
###end p 8
###begin p 9
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
Because many Hox genes have been found to play an important role in the regulation of blood stem cell proliferation and differentiation (recently reviewed in Argiropoulos and Humphries [17]), and the Hox-3 paralog group in particular has been shown to promote neovascularization [3, 18, 19], we hypothesized that HOXA3-augmented diabetic wound healing may in part arise from its potential impact on BMDCs. This could occur via modulation of BMDC mobilization, recruitment, or differentiation of stem/progenitor cells, or any combination of these processes during wound repair and regeneration. Here we show that sustained expression of HOXA3 in diabetic wounds is accompanied by specific transcriptional changes in the wound microenvironment that modulate both the quantity and type of BMDCs recruited to cutaneous wounds, accelerating tissue repair.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Strains and Bone Marrow Chimeras
###end title 11
###begin p 12
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(db/db)</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lepr</italic>
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 238 240 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>db</italic></sup>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(db/+)</italic>
###xml 875 876 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 932 937 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 941 945 940 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/+</italic>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">Mice</span>
All animals used in this study were housed in the University of California San Francisco (UCSF) animal care facility, and the UCSF Committee on Animal Research approved all procedures on animals. Male diabetic (db/db) mice (B6.Cg-m+/+Leprdb/J; Jackson Laboratory, Bar Harbor, ME, ) and heterozygous (db/+) controls age 8-10 weeks were lethally irradiated (10 Gy). Bone marrow was harvested from 8- to 10-week-old female donor mice ubiquitously expressing enhanced green fluorescent protein (GFP) (C57BL/6-Tg(CAG-EGFP)1Osb/J; Jackson Laboratory) by flushing the femurs and tibiae with Dulbecco's modified Eagle's medium. Bone marrow was passed through a sterile 27-gauge needle and through a 70-mum nylon mesh cell strainer (BD Biosciences, San Diego, ) and rinsed once in phosphate-buffered saline (PBS), and viable cells were counted. Chimeras were generated by injecting 106 viable cells into the retro-orbital plexus of the male db/db or db/+ mice approximately 6 hours after irradiation. Mice were maintained on antibiotic-treated water (Ditrim, 5 ml/200 ml) for 2 weeks, and allowed 4 weeks for reconstitution before any further procedures were performed.
###end p 12
###begin title 13
Wound Model and Methylcellulose-Mediated Gene Transfer
###end title 13
###begin p 14
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 390 391 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 589 595 589 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(db/+)</italic>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/+</italic>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 915 920 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 978 979 978 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1008 1009 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1278 1287 1278 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 1408 1409 1408 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1278 1281 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1927 1931 <span type="species:ncbi:10090">Mice</span>
Prior to wounding, blood glucose levels were measured after a 12-hour fast using a standard portable blood glucose meter and GFP chimerism was measured by flow cytometry as described below. After confirmation of hyperglycemia in db/db recipients and GFP chimerism in all recipients, mice were wounded by making an 8-mm full thickness excisional wound on the dorsum as described previously [3]. Skin removed from the wound at this time was used for day 0. For chimera studies, db/db mice were randomly grouped into experimental and control groups (n = 6-8 for each group), and heterozygous (db/+) control groups (n = 3-4) for each time point (day 0, day 7, and day 14). For bone marrow and peripheral blood wound response quantitative reverse-transcription polymerase chain reaction (qRT-PCR) experiments, two db/+ and two db/db mice were used for each time point (day 0 and day 4). For microarray experiments, four db/db mice were used, split into two groups, one experimental (n = 2) and one control group (n = 2), with skin from all four mice pooled for two technical replicates at the day 0 time point. Two mice were used from each group at day 4 for a total of four biological replicates. In each study, experimental groups were treated with cytomegalovirus promoter-driven CMV-HOXA3 expression plasmid and control groups were treated with vector control. Plasmids were prepared as described previously [3], using 25 mug of DNA per 0.8-cm diameter wound, mixed, and dried down in 1% methyl cellulose to form a flat pellet. Twenty-five micrograms was determined as the optimal amount of plasmid DNA to achieve maximal expression, while minimizing toxicity, using a dose curve analysis of 5, 15, 25, 35, and 50 mug, Western blot quantification and qualitative wound healing analysis. Plasmid pellets were applied directly to the open wound at the time of wounding. Animals were housed individually and wounds left undressed. Mice were anesthetized prior to wounding with isoflurane gas (2%) in oxygen, and received 0.05 mg/kg buprenorphine subcutaneously at the time of wounding followed by a second dose 12 hours later.
###end p 14
###begin title 15
Immunohistochemistry
###end title 15
###begin p 16
###xml 553 559 <span type="species:ncbi:9986">Rabbit</span>
###xml 630 633 <span type="species:ncbi:10116">rat</span>
###xml 683 687 <span type="species:ncbi:9925">goat</span>
###xml 759 765 <span type="species:ncbi:9986">rabbit</span>
###xml 799 806 <span type="species:ncbi:9031">chicken</span>
###xml 925 931 <span type="species:ncbi:9793">donkey</span>
###xml 937 943 <span type="species:ncbi:9986">rabbit</span>
###xml 956 960 <span type="species:ncbi:9925">goat</span>
###xml 966 972 <span type="species:ncbi:9986">rabbit</span>
###xml 984 990 <span type="species:ncbi:9793">donkey</span>
###xml 996 999 <span type="species:ncbi:10116">rat</span>
###xml 1013 1017 <span type="species:ncbi:9925">goat</span>
###xml 1023 1026 <span type="species:ncbi:10116">rat</span>
###xml 1038 1044 <span type="species:ncbi:9793">donkey</span>
###xml 1050 1054 <span type="species:ncbi:9925">goat</span>
###xml 1064 1068 <span type="species:ncbi:9925">goat</span>
###xml 1074 1081 <span type="species:ncbi:9031">chicken</span>
For the chimera studies, wounds were harvested at days 0, 7, and 14, incubated in formalin for 3 days, and embedded in paraffin. Five-mum sections were cut, dried for at least 24 hours, and stored at room temperature or processed immediately. Sections were deparaffinized in three changes of xylenes, followed by ethanol and methanol washes, and then rehydrated. Antigen retrieval was performed by microwaving sections in sodium citrate buffer (10 mM Na citrate, 0.05% Tween 20, pH 6.0) for 20 minutes, followed by standard immunofluorescent detection. Rabbit anti-GFP (Abcam, Cambridge, U.K., ) was used at a dilution of 1:1000; rat anti-Cd45 (Invitrogen, Carlsbad, CA, ), at 1:50; goat anti-Cd34 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, ), at 1:100; rabbit anti-Cd29 (Abcam), at 1:250; and chicken anti-GFP (Abcam), at 1:500. Primary antibodies were detected with combinations of the following secondaries at 1:400: donkey anti-rabbit Alexa555 or goat anti-rabbit Alexa 488, donkey anti-rat Alexa 488 or goat anti-rat Alexa 555, donkey anti-goat Cy5, and goat anti-chicken Alexa 647, as appropriate.
###end p 16
###begin title 17
Flow Cytometry
###end title 17
###begin p 18
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
Blood samples were analyzed from chimeras prior to wounding (GFP only) and on days 0, 4, 7, and 14, as follows: approximately200 mul of blood from each mouse was collected using a cheek lancet (Goldenrod; Medipoint, Minneola, NY, ) into 50 mul of heparin solution, followed by ammonium chloride red blood cell (RBC) lysis and removal by centrifugation. Cleared blood was then analyzed by flow cytometry (LSR-II; BD Biosciences) and accompanying DIVA software (BD Biosciences) and FlowJo software (TreeStar, Inc., Ashland, OR, ). Samples were incubated with the following antibodies: anti-Cd34 Pacific Blue (1:20), anti-Cd133 PE (1:50), anti-Cxcr4 APC (1:20), anti-Cd45 PE-Cy7 (1:2000), and anti-Cd117 PE-Cy5.5 (1:200) (eBioscience, San Diego, ).
###end p 18
###begin title 19
RNA Isolation and Quantitative RT-PCR
###end title 19
###begin p 20
###xml 726 738 706 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa3, Ccl2,</italic>
###xml 753 777 730 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">[Defb15], Myd88, Tollip,</italic>
###xml 782 791 759 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Histone2A</italic>
###xml 794 797 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine skin/wounds were harvested at the specified time points indicated and flash-frozen on dry ice and stored at -80degrees C or stored in RNA later (Ambion, Austin, TX, ) at 4degrees C. Tissue was then briefly rinsed in RNAse-free PBS (Ambion). RNA was isolated by tissue homogenization in Trizol (Invitrogen) with a rotor-stater homogenizer (Omni International, Marietta, GA, ). RNA was analyzed using a UV spectrophotometer and gel electrophoresis and stored at -80degreesC. One mug of total RNA was used in reverse transcription reactions using random primers in a total volume of 25 mul. qRT-PCRs were performed at least three times on each sample using approximately 25 ng of template cDNA, Taqman probe/primer pairs (Hoxa3, Ccl2, beta-defensin [Defb15], Myd88, Tollip, and Histone2A & 18S as reference controls), and universal master mix for each gene analyzed (Applied BioSystems, Foster City, CA, ) on an ABI Prism SDS 7000 or Step-One-Plus machine according to the manufacturer's instructions. Data were analyzed with SDS 7000 or Step-One-Plus companion software and Microsoft Excel (Microsoft, Redmond, WA, ).
###end p 20
###begin title 21
Microarray Analysis and Validation
###end title 21
###begin p 22
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 759 760 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1053 1054 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1300 1302 1300 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 247 253 <span type="species:ncbi:10090">murine</span>
Total RNA harvested from day 0, 4, and 7 wounds and universal mouse reference RNA (Stratagene, La Jolla, CA, ) were amplified and labeled using the Amino Allyl MessageAmp II kit with Cy5 and Cy3 dUTP (Ambion). Labeled RNAs were then hybridized to murine whole genome expression (MEEBO) arrays (Stanford University). Arrays were scanned and analyzed using Stanford functional genomics facility scanner and accompanying software (Agilent Technologies, Palo Alto, CA, ). All arrays were inspected for hybridization defects using MEEBO-specific quality plots from the Bioconductor package arrayQuality [20], and print-tip loess normalization was used to correct for any dye or spatial biases [21]. Differentially expressed genes were determined using a Student's t test (p < .05), followed by additional intensity and fold-change filtering (log-intensity > 8 and absolute fold-change > 1.5). Differentially expressed genes were further analyzed for functional groups using WebGestalt () [22]. The minimum number of overrepresented genes was set to 3, and a p value cutoff of .05 was used for Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) process identification. Complete data files are available at National Center for Biotechnology Information's Gene Expression Omnibus [23] . Genes selected for validation and further analyses were quantified using qRT-PCR on RNA from microarray samples and at least two other samples collected independently.
###end p 22
###begin title 23
Statistical Analyses
###end title 23
###begin p 24
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical significance was determined using a Student's t test for experiments where control and experimental groups were being compared, as noted in figures or text. Statistical significance was determined using analysis of variance, followed by a post hoc Tukey's test when more than two groups were being compared. A p value of < .05 was considered significant, unless otherwise noted.
###end p 24
###begin title 25
RESULTS
###end title 25
###begin title 26
###xml 70 74 <span type="species:ncbi:10090">Mice</span>
Recruitment of BMDCs to Wounds Is Significantly Increased in Diabetic Mice
###end title 26
###begin p 27
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lepr</italic>
###xml 490 492 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 490 495 490 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>db</italic>&#8722;/&#8722;</sup>
###xml 495 502 495 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;db/db&#8221;</italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lepr</italic>
###xml 527 529 527 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 527 532 527 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>db</italic>+/&#8722;</sup>
###xml 532 538 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;db/+&#8221;</italic>
###xml 676 678 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 756 763 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 1295 1296 1290 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1450 1457 1445 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B</xref>
###xml 1907 1914 1878 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
###xml 1916 1918 1887 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">1D</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 647 654 <span type="species:ncbi:9031">chicken</span>
###xml 1560 1564 <span type="species:ncbi:10090">mice</span>
###xml 1707 1711 <span type="species:ncbi:10090">mice</span>
###xml 1815 1819 <span type="species:ncbi:10090">mice</span>
Diabetic wounds in both rodent models and human patients exhibit increased inflammation [24, 25]. However, recruitment of total BMDCs to diabetic wounds, which contain stem/progenitor cell types as well as inflammatory precursors, has not been previously analyzed, although addition of mononuclear bone marrow cells to diabetic wounds has been shown to improve healing [26]. To compare recruitment of BMDCs in diabetic and nondiabetic mice, we reconstituted lethally irradiated mice (6 Leprdb-/-"db/db" diabetic mice and 4 Leprdb+/-"db/+" nondiabetic littermate controls) with bone marrow from donor mice ubiquitously expressing GFP driven by the chicken beta-actin promoter [27]. After 4 weeks of reconstitution, chimerism was analyzed by flow cytometry (Fig. 1A), with the mean percentage of GFP-positive cells in RBC-cleared blood greater than 80% (82.07 +/- 4.05 SEM). Sections through unwounded skin (day 0) and 8-mm full thickness excisional wounds (day 7) of GFP chimeras were analyzed with hematoxylin and eosin to obtain similar positions within the wound tissue for further analysis. The day 7 time point was selected as it represents the peak of angiogenesis, and is well after the peak of the inflammatory phase, which occurs at days 3-4. Parallel sections were then analyzed for GFP+ cells, relative to 4',6-diamidino-2-phenylindole (DAPI)-positive cells, in three separate areas near the wound edge to obtain an average for each wound (Fig. 1B). Although there is no significant difference in BMDC numbers in the skin of diabetic and nondiabetic mice prior to injury (day 0), there is a dramatic increase in total BMDC wound recruitment to cutaneous wounds by 7 days after injury. Nondiabetic mice exhibit an approximately3-fold increase in BMDCs in day 7 wounds compared with day 0, whereas diabetic mice exhibit an approximately18-fold increase in BMDCs in day 7 wounds compared with day 0 (Fig. 1C, 1D).
###end p 27
###begin p 28
###xml 151 155 151 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A):</bold>
###xml 290 294 290 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B):</bold>
###xml 685 689 685 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C):</bold>
###xml 977 978 977 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 986 990 986 990 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D):</bold>
###xml 1096 1099 1096 1099 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1140 1144 <span type="species:ncbi:10090">mice</span>
Bone marrow-derived cell (BMDC) recruitment to diabetic wounds in GFP bone marrow chimeras is dramatically increased compared with nondiabetic wounds. (A): Representative bone marrow chimerism flow cytometry analysis of peripheral blood using non-GFP chimera siblings as negative controls. (B): Representative day 7 wound section stained with hematoxylin and eosin is shown in the upper half of the panel. A graphic of this section is shown in the lower half of the panel. Red cross-hatching represents the wound. Rectangles 1, 2, and 3 represent areas near the wound boundary imaged using confocal microscopy to obtain average recruited BMDC number for each animal. Scale bar = 1 mm. (C): Relative number of BMDCs (normalized using DAPI-stained nuclei to account for cell density differences) recruited to the wound site in unwounded nondiabetic controls (wt D0), unwounded diabetic (db D0), day 7 wounds from nondiabetic (wt D7) and diabetic (db D7) mice. Asterisk indicates p < .05. (D): Representative images of DAPI staining and GFP immunofluorescence of BMDCs in wound sections as shown in (B) from nondiabetic (wt) and diabetic (db) mice at day 0 and day 7 following wounding. Scale bar = 100 mum. Abbreviations: d, dermis, DAPI, 4',6-diamidino-2-phenylindole; db, diabetic; D0, day 0; D7, day 7; ep, epithelium, es, eschar, Freq, frequency; FSC-H, forward scatter height; GFP, green fluorescent protein; gr, granulation tissue; m, muscle; neg cntl, negative control; SSC-H, side scatter height; wt, wild type.
###end p 28
###begin title 29
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
Sustained Expression of HOXA3 in Diabetic Wounds Reduces the Number of Recruited BMDCs
###end title 29
###begin p 30
###xml 100 109 100 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 479 486 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(db/db)</italic>
###xml 517 526 516 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 627 633 625 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(db/+)</italic>
###xml 820 829 817 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 881 882 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 916 917 913 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 987 988 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 998 1003 995 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 1022 1031 1019 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 1101 1108 1098 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 1110 1112 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">2B</xref>
###xml 100 103 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 517 520 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 820 823 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1022 1025 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
As we previously demonstrated an increase in neovascularization due to wound-specific expression of CMV-HOXA3 [3], we wished to test whether HOXA3 had any effect on recruitment of BMDCs, which are known to play a role in this process. We used GFP+ bone marrow chimeras to enumerate and identify BMDCs at different time points during the repair process. Three groups of mice were wounded with 8-mm-diameter full thickness excisional wounds as described previously [3]: 6 diabetic (db/db) mice were treated with 25 mug CMV-HOXA3 plasmid; 6 diabetic mice were treated with 25 mug pcDNA3.1myc/his (empty vector), and 4 nondiabetic (db/+) mice were treated with 25 mug pcDNA3.1myc/his (empty vector), as this amount was determined to be optimal (see Materials and Methods for details). Nondiabetic mice were not treated with CMV-HOXA3 as this has no observable effect on wound healing [3]. Immunolocalization of total GFP+ cells revealed that at days 7 and 14 after wounding the number of GFP+ cells in db/db mice treated with CMV-HOXA3 was significantly reduced compared with vector control-treated mice (Fig. 2A, 2B).
###end p 30
###begin p 31
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 113 117 113 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A):</bold>
###xml 303 312 303 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 343 347 342 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B):</bold>
###xml 509 518 508 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 602 603 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 661 670 660 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 710 719 709 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 769 778 768 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 303 306 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 509 512 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 661 664 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 710 713 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 769 772 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Expression of HOXA3 during diabetic wound repair modulates the recruitment of bone marrow-derived cells (BMDCs). (A): Representative images of wound sections from diabetic mice with GFP immunofluorescent detection of BMDCs at days 0, 7, and 14 following wounding, treated with control (empty vector) or CMV-HOXA3 plasmid. Scale bar = 100 mum. (B): Relative number of BMDCs (normalized against 4',6-diamidino-2-phenylindole [DAPI]-stained nuclei) in wounds from diabetic mice treated with control (DB+cntl) or CMV-HOXA3 plasmid (DB+A3) at day 0, day 7, and day 14 following wounding. Asterisk indicates p < .05. Abbreviations: DB+A3, diabetic wound treated with CMV-HOXA3; db+A3 D7, diabetic wound treated with CMV-HOXA3 at day 7; db+A3 D14, diabetic wound treated with CMV-HOXA3 at day 14; DB+cntl, diabetic wound treated with control; db+cntl D7, diabetic wound treated with control at day 7; db+cntl D14, diabetic wound treated with control at day 14; db D0, diabetic wound at day 0; GFP, green fluorescent protein.
###end p 31
###begin title 32
HOXA3 Suppresses Leukocyte Recruitment to Diabetic Wounds
###end title 32
###begin p 33
###xml 281 289 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3</xref>
###xml 476 477 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 481 482 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 586 593 586 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3A</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">3B</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
Because the diabetic wound environment exhibits poor tissue repair, and is associated with chronic inflammation, we hypothesized that a larger percentage of the BMDCs recruited to these wounds at day 7 were leukocytes, compared with nondiabetic mice. Not surprisingly, as shown in Figure 3, double labeling of GFP and Cd45 (a pan-leukocyte marker) revealed that although diabetic mice have similar numbers of inflammatory cells at day 0, they showed a fivefold increase in GFP+Cd45+ leukocytes in day 7 wounds and a twofold increase in day 14 wounds compared with nondiabetic controls (Fig. 3A, 3B). This is consistent with previous reports that demonstrate both increased numbers and retention time of inflammatory cells in skin after injury in diabetic mice compared with nondiabetic mice [15, 16].
###end p 33
###begin p 34
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 81 85 81 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A):</bold>
###xml 208 217 208 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 326 330 325 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B):</bold>
###xml 384 385 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 393 394 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 398 399 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 520 529 519 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 624 633 623 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 673 682 672 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 732 741 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 208 211 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 520 523 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 624 627 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 673 676 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 732 735 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Expression of HOXA3 in diabetic wounds suppresses inflammatory cell recruitment. (A): Representative images of sections from day 0, 7, and 14 wounds from nondiabetic and diabetic mice treated with control or CMV-HOXA3 plasmid. Upper panels of each group show GFP+ cells and lower panels show Cd45+ cells. Scale bar = 100 mum. (B): Bar graphs showing normalized relative numbers of GFP+ and GFP+Cd45+ (leukocyte) cells recruited to the wounds at days 0, 7, and 14 in nondiabetic and diabetic mice treated with control or CMV-HOXA3 plasmid. Abbreviations: D0, day 0; D7, day 7; D14, day 14; db+A3, diabetic wound treated with CMV-HOXA3; db+A3 D7, diabetic wound treated with CMV-HOXA3 at day 7; db+A3 D14, diabetic wound treated with CMV-HOXA3 at day 14; db+C and db+c, diabetic wound treated with control; db D0, diabetic wound at day 0; db D7, diabetic wound at day 7; db D14, diabetic wound at day 14; GFP, green fluorescent protein; hc+c, heterozygous control + control plasmid; non-db D0, nondiabetic wound at day 0; non-db D7, nondiabetic wound at day 7; non-db D14, nondiabetic wound at day 14.
###end p 34
###begin p 35
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 376 385 376 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 440 441 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 560 567 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3A</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">3B</xref>
###xml 735 736 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 740 741 740 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 861 866 861 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 376 379 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
Furthermore, based on our results demonstrating that HOXA3 gene transfer resulted in an overall reduction in the number of BMDCs, we wished to test whether sustained expression of HOXA3 might result in a reduction in the number of leukocytes recruited to the wound, and perhaps promote healing by suppressing the chronic inflammation associated with diabetic wounds. We found CMV-HOXA3 treatment significantly reduced the number of GFP+Cd45+ leukocytes present in the wound area at days 7 and 14 after wounding compared with empty vector control-treated mice (Fig. 3A, 3B). However, flow cytometry analysis of cleared (RBC-lysed) peripheral blood at days 0, 4, and 7 revealed that there was no significant difference in circulating GFP+Cd45+ cells at any of the assayed time points (data not shown), suggesting that the reduction of leukocytes in the wounds of HOXA3-treated diabetic mice was due to specifically suppressing leukocyte recruitment to the wound or retention at the wound site, rather than a reduction in mobilization from the bone marrow.
###end p 35
###begin title 36
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
HOXA3 Expression in Diabetic Wounds Stimulates Bone Marrow Mobilization and Recruitment of EPCs
###end title 36
###begin p 37
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 508 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3</xref>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 534 543 534 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 583 584 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 658 665 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4A</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">4B</xref>
###xml 1145 1147 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1316 1318 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1482 1487 1479 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 534 537 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1236 1242 <span type="species:ncbi:10090">murine</span>
Because HOXA3 strongly stimulates neovascularization in the wound [3], we also investigated whether EPC recruitment to the wound was influenced. Immunolocalization of EPCs was performed using double and/or triple labeling of antibodies against GFP, Cd133, and Cd34. The antibody combination detecting GFP, Cd133, and Cd34 marks a population of very early EPCs, whereas the GFP+Cd34+Cd133- cells are regarded as more mature EPCs [28, 29]. Despite the reduction in total BMDCs and Cd45+ cells shown in Figure 3, db/db mice treated with CMV-HOXA3 displayed a significant increase in GFP+Cd34+ EPCs in wounds at day 7 compared with vector control-treated db/db (Fig. 4A, 4B). This relative increase was still present at day 14, although to a much reduced extent (not shown). Cd133 was not detectable in the wound tissue, suggesting that cells retained in the wound were more mature EPCs. Additionally, because multipotent MSCs can express Cd34 and can also be recruited from the bone marrow, as well as surrounding adipose tissue, and contribute to angiogenesis we could not rule out that some of these cells were MSCs as opposed to "classic" EPCs [30]. To detect non-BM-derived MSCs, we used a combination of Cd29 (integrin beta-1), which murine MSCs consistently express, Cd45, which MSCs consistently do not express [30], and GFP to mark cells derived from the bone marrow (this was also negatively selected against). We found no difference in non-BM-derived MSC recruitment between HOXA3-treated and control-treated wounds (data not shown).
###end p 37
###begin p 38
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 103 107 103 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A):</bold>
###xml 241 250 241 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 374 378 373 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B):</bold>
###xml 402 403 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 578 587 577 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 605 609 604 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C):</bold>
###xml 754 763 753 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 823 824 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 829 830 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 834 835 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 855 859 854 858 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D):</bold>
###xml 959 968 958 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 994 998 993 997 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E):</bold>
###xml 1143 1152 1142 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 1212 1213 1211 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1218 1219 1217 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1223 1224 1222 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1244 1248 1243 1247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F):</bold>
###xml 1348 1357 1347 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 1458 1467 1457 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 1523 1532 1522 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 1818 1827 1817 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 241 244 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 578 581 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 754 757 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 959 962 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1143 1146 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1348 1351 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1458 1461 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1523 1526 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1818 1821 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Expression of HOXA3 in diabetic wounds stimulates mobilization of endothelial progenitor cells (EPCs). (A): Representative images of wound sections from nondiabetic mice (non-db) and diabetic mice (db) treated with control (empty vector) or CMV-HOXA3 plasmid. Upper panels show GFP+ bone marrow-derived cells at day 7 and lower panels show Cd34+ cells. Scale bar = 100 mum. (B): Percentage of total GFP+ cells that are double positive for Cd34 recruited to the wound at day 7 in nondiabetic mice treated with control plasmid, and diabetic mice treated with control (db+cntl) or CMV-HOXA3 (db+A3) plasmid. (C): Representative scatter plots of cleared peripheral blood from diabetic GFP chimeras at day 4 following wounding treated with control (db2+c) or CMV-HOXA3 (db7+A3) plasmid. Cells in the upper right quadrant are GFP+Cd133+Cd34+ (early EPC) cells. (D): Quantification of early EPCs in peripheral blood at day 4 following wounding of control-treated or CMV-HOXA3-treated diabetic wounds. (E): Representative scatter plots of cleared peripheral blood from diabetic GFP chimeras at day 7 following wounding treated with control (db2+c) or CMV-HOXA3 (db7+A3) plasmid. Cells in the upper right quadrant are GFP+Cd133+Cd34+ (early EPC) cells. (F): Quantification of early EPCs in peripheral blood at day 7 following wounding of control-treated or CMV-HOXA3-treated diabetic wounds. Abbreviations: APC, allophycocyanin; db+A3 D7, diabetic wound treated with CMV-HOXA3 at day 7; db+a3 and db+A3, diabetic wound treated with CMV-HOXA3 at day 3; db+C, diabetic wound treated with control; db+cntl, diabetic wound treated with control; db+cntl D7, diabetic wound treated with control at day 7; db1+C, diabetic wound 1 treated with control; db2+C, diabetic wound 2 treated with control; db7+A3, diabetic wound treated with CMV-HOXA3 at day 7; FMO, fluorescence minus one control; GFP, green fluorescent protein; non-db D7, nondiabetic wound at day 7; non db, nondiabetic wound; PB, peripheral blood; PE, phycoerythrin.
###end p 38
###begin p 39
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 272 281 272 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/+</italic>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 593 594 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 649 650 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 712 721 712 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 730 735 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 794 801 794 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4C</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">4F</xref>
###xml 971 972 971 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 272 275 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 712 715 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
To test whether the differences in EPCs present in HOXA3-treated wounds at day 7 were due to enhanced EPC recruitment, and/or could be attributed to increased mobilization of EPCs from the bone marrow, we analyzed blood samples collected both from db/db mice treated with CMV-HOXA3 or control plasmid, as well as db/+ mice treated with control plasmid. Flow cytometry was performed to analyze cleared peripheral blood samples using GFP, Cd34, and Cd133 as markers of EPCs at the following time points: day 0, day 4, day 7, and day 14. Although there were no significant differences in GFP+Cd34+Cd133- cells (more mature EPCs), "early" EPCs (GFP+Cd34+Cd133+ cells) showed a significant increase in circulation in CMV-HOXA3-treated db/db mice compared with controls at days 4 and 7 after injury (Fig. 4C--4F). Thus HOXA3 functions not only to reduce inflammatory cell infiltration into wounds, but also to selectively mobilize and recruit EPCs, and possibly BM-derived Cd34+ MSCs to wounds, promoting healing.
###end p 39
###begin title 40
Analysis of Cell-Specific Transgene Expression
###end title 40
###begin p 41
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 680 687 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5A</xref>
###xml 724 729 724 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa3</italic>
###xml 800 805 800 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 850 857 850 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5B</xref>
###xml 936 937 936 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 956 957 956 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1194 1203 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5C</xref>
###xml 1334 1339 1334 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 491 496 <span type="species:ncbi:9606">human</span>
###xml 1173 1176 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Because changes in Hox gene expression have been shown to have dramatic effects on bone marrow-derived progenitor cells, including increasing proliferation and self-renewal in the stem cell compartment (recently reviewed in Argiropoulos and Humphries [17]), we evaluated whether local gene transfer of HOXA3 to wounds could also result in transfection of circulating cells or bone marrow-resident cells, and thus alter their fate. Quantitative PCR analyses using primer sets specific to the human HOXA3 transgene revealed that although the HOXA3 transgene was easily detectable in wound tissue 4 days after gene transfer, it was not detectable in peripheral blood or bone marrow (Fig. 5A). Accordingly, levels of endogenous Hoxa3 expression were similar in circulating cells and bone marrow cells of HOXA3-treated and vector control-treated animals (Fig. 5B). We next investigated whether recruited BMDCs, in particular leukocytes (Cd45+) and/or EPCs (Cd34+) cells, were transfected by application of transgene to the wound, thus affecting their behavior within the wound. To avoid problems with detection of endogenous Hoxa3, we performed a gene transfer experiment using CMV-GFP. As shown in Figure 5C, expression of the transgene in wounds at day 4 is overwhelmingly biased toward leukocytes, suggesting that the largest effect of HOXA3 gene transfer to wounds is due to direct HOXA3-mediated changes in leukocyte behavior.
###end p 41
###begin p 42
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa3</italic>
###xml 117 121 117 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A):</bold>
###xml 304 313 304 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 402 406 402 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B):</bold>
###xml 504 513 504 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa3</italic>
###xml 571 575 571 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C):</bold>
###xml 960 961 960 961 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1099 1105 1098 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3;</italic>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 304 307 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 504 507 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The HOXA3 transgene is not expressed in peripheral blood or bone marrow cells and has no effect on endogenous Hoxa3. (A): Quantitative reverse-transcription polymerase chain reaction (RT-PCR) of RNA isolated from wound tissue, peripheral blood, and bone marrow from diabetic mice treated with control or CMV-HOXA3 plasmid showing relative expression of the HOXA3 transgene at day 4 following wounding. (B): Quantitative RT-PCR of RNA isolated from wound tissue from diabetic mice treated with control or CMV-HOXA3 plasmid showing relative expression of endogenous Hoxa3. (C): Analysis of transgene expression 4 days after wounding and gene transfer. Transgene expression is shown in green in the upper left panel, white arrowhead indicates expression in hair follicle cells, yellow arrowhead indicates expression in basal keratinocytes, and red arrowhead indicates expression in leukocytes. Leukocytes are marked with red (Cd45) in upper middle panel, and Cd34+ cells are shown blue in upper right panel. Lower panels show merged channels as indicated. Scale bar = 100 mum. Abbreviations: +A3, plus HOXA3; BM, bone marrow; cntl, control; PB, peripheral blood; Tg, transgene; Wnd, wound tissue.
###end p 42
###begin title 43
Microarray Analyses of HOXA3-Mediated Changes in Wound Tissue Gene Expression
###end title 43
###begin p 44
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 277 286 277 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 545 552 545 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6A</xref>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 277 280 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To investigate how HOXA3 expression in wound tissue alters gene expression to control selective recruitment of BMDC populations, we used MEEBO arrays (see Materials and Methods) to identify differentially expressed genes in cutaneous wounds from db/db mice treated with either CMV-HOXA3 or control plasmid. We chose day 4 as the time point to harvest the wounds for RNA isolation, as this day represents the transition from inflammatory to proliferative phase and precedes the observed differences in BMDC mobilization and recruitment at day 7 (Fig. 6A).
###end p 44
###begin p 45
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 143 147 143 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A):</bold>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 382 386 382 386 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B):</bold>
###xml 452 461 448 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 473 477 469 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C):</bold>
###xml 637 641 629 633 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D):</bold>
###xml 653 657 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnfa</italic>
###xml 692 701 684 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 738 742 730 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E):</bold>
###xml 797 806 789 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 837 841 829 833 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F):</bold>
###xml 991 995 983 987 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G):</bold>
###xml 1055 1060 1047 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 1168 1177 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf-&#945;</italic>
###xml 1328 1333 1312 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 199 203 <span type="species:ncbi:10090">Mice</span>
###xml 452 455 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 692 695 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 797 800 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Expression of HOXA3 in diabetic wounds results in activation of proangiogenic genes and repression of proinflammatory genes at the wound site. (A): Schematic representation of microarray experiment. Mice were split into two groups; unwounded skin was harvested at day 0 and wounded skin, at day 4. Gene expression profiles of control-treated and HOXA3-treated wounds were compared. (B): NF-kappaB pathway member gene expression analysis in response to CMV-HOXA3 treatment. (C): Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) validation of selected genes that are central to NF-kappaB pathway signal transduction. (D): qRT-PCR of Tnfa expression in control-treated and CMV-HOXA3-treated wounds at days 0, 4, and 7. (E): Proangiogenic gene expression analysis in response to CMV-HOXA3 treatment of diabetic wounds. (F): qRT-PCR validation of selected genes known to promote endothelial progenitor cell (EPC) mobilization and recruitment to sites of neovascularization. (G): Model of HOXA3 function during wound repair. Expression of HOXA3 in diabetic wounds results in downregulation of members of the NF-kappaB pathway, leading to a decrease in Tnf-alpha expression. This results in reduced inflammation and a wound environment more conducive to repair and vascular regeneration. Abbreviations: +A3, plus HOXA3; cntl, control; downreg, downregulation; NF-kappaB, nuclear factor kappaB; qPCR, quantitative polymerase chain reaction; TNF-alpha, tumor necrosis factor alpha; upreg, upregulation.
###end p 45
###begin p 46
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 209 200 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMV-HOXA3</italic>
###xml 221 228 221 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6A</xref>
###xml 253 259 253 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">data 1</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">2</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">1</xref>
###xml 1006 1013 994 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6B</xref>
###xml 1092 1097 1076 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 1102 1108 1086 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tollip</italic>
###xml 1173 1180 1157 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6C</xref>
###xml 1200 1209 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf-&#945;</italic>
###xml 1317 1322 1293 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 1338 1347 1314 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf-&#945;</italic>
###xml 1390 1391 1362 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1411 1412 1383 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1422 1429 1394 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6D</xref>
###xml 1610 1611 1582 1583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1615 1616 1587 1588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1682 1687 1654 1659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 1716 1721 1688 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 26 29 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 200 203 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1299 1303 <span type="species:ncbi:10090">mice</span>
Day 4 wounds treated with CMV-HOXA3 showed significant differential expression of 837 known genes by at least 1.5-fold (p < .05), with 505 genes downregulated and 332 genes upregulated in response to CMV-HOXA3 treatment (Fig. 6A, supporting information data 1 and 2; complete data files have been deposited at ). Analyses of the HOXA3-repressed gene set revealed regulatory pathways inhibited by HOXA3. Seven of these pathways are specific to leukocyte signaling and differentiation (Table 1, left-hand column, highlighted pathways), consistent with our findings that HOXA3 suppresses the inflammatory response. In particular, many members of the nuclear factor kappaB (NF-kappaB) pathway were repressed, including interleukin 1 alpha, Tnf receptor-associated factor 1, interleukin-1 receptor-associated kinase 2, myeloid differentiation primary response gene 88, toll-interacting protein, TNFAIP3-interacting protein 1, B-cell leukemia/lymphoma 10, and NF-kappaB inhibitor-interacting Ras-like protein 2 (Fig. 6B). Because of their central role in NF-kappaB signaling in inflammatory cells, Myd88 and Tollip were selected for further analysis and validated using qRT-PCR (Fig. 6C). We also analyzed Tnf-alpha expression, as it is one of the major targets of NF-kappaB activation. Not surprisingly, mice treated with HOXA3 showed reduced Tnf-alpha transcriptional activation at both day 4 (p = .078) and day 7 (p = .056) (Fig. 6D). This HOXA3-mediated repression of proinflammatory genes at day 4 is not due to a decrease in the number of inflammatory cells present in the wound at day 4, as the numbers of GFP+Cd45+ cells in the wound at day 4 did not significantly differ between HOXA3-treated and control-treated db/db wounds at this time point (data not shown). All together, these data suggest that HOXA3 suppresses the exacerbated inflammatory cell response found in diabetic chronic wounds in part by silencing the NF-kappaB pathway in cells in the wound by day 4, resulting in a significant reduction of inflammatory cells in the wound by day 7, coinciding with the peak of the neovascularization phase.
###end p 46
###begin p 47
Regulatory pathways modulated by HOXA3 during wound repair
###end p 47
###begin p 48
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">1</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">1</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1013 1020 1013 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6E</xref>
###xml 1065 1069 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vegf</italic>
###xml 1143 1155 1143 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(MCP-1/Ccl2)</italic>
###xml 1160 1167 1160 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Defb15,</italic>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 1230 1232 1230 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 1285 1292 1285 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6F</xref>
###xml 1310 1315 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lrp1,</italic>
###xml 1345 1347 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1349 1351 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 1417 1419 1413 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1442 1449 1438 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6E</xref>
Analyses of the much smaller set of upregulated genes in db/db wounds at day 4 did not reveal any KEGG pathways that are specific to neovascularization, per se, however several of the pathways promoted by HOXA3 are known to contribute to neovascularization, and in particular, to endothelial cell migration (Table 1, right column, highlighted in yellow), such as calcium signaling, glycan biosynthesis, and vascular endothelial growth factor (VEGF) signaling pathway components. GO function analyses of this gene set suggest HOXA3 promotes cell-cell signaling pathways and neurophysiological processes (Table 1, right column, highlighted in yellow), both of which have also been shown to play a significant role in neovascularization (reviewed in Lok et al [31] and Scott et al [32]). However, because HOXA3 has been previously shown to promote angiogenesis and endothelial cell migration, we chose to focus on factors from this gene set that directly promote EPC mobilization and EPC/endothelial cell migration (Fig. 6E). Although we did not detect any changes in Vegf expression, chemoattractant molecules monocyte chemoattractant protein-1 (MCP-1/Ccl2) and Defb15, both potent inducers of EPC mobilization and recruitment [33, 34], were independently confirmed by quantitative PCR (Fig. 6F). Interestingly, Lrp1, which is both proangiogenic [35, 36] and anti-inflammatory, via inhibition of the NF-kappaB pathway [37], was also increased (Fig. 6E).
###end p 48
###begin p 49
###xml 626 633 618 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6G</xref>
All together, these data suggest that HOXA3 acts within wound tissue to increase expression of angiogenic and EPC recruiting factors, while also repressing expression of genes that contribute to inflammatory cell activation and recruitment, resulting in enhanced neovascularization and tissue repair. Suppression of the NF-kappaB pathway by HOXA3 results in a reduction of TNF-alpha and inflammation, which are associated with the chronic wound environment and reduced HOXA3 expression characteristic of diabetic wounds. This "rescue" of the chronic wound environment is, in turn, associated with enhanced neovascularization (Fig. 6G).
###end p 49
###begin title 50
DISCUSSION
###end title 50
###begin p 51
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
In this study we have demonstrated that sustained expression of HOXA3 in diabetic wounds significantly alters BMDC recruitment in response to wounding. We show that local expression of HOXA3 in wound tissue not only results in increased mobilization and recruitment of EPCs, but also suppresses the excessive inflammatory response characteristic of diabetic wounds. Together, the enhanced angiogenic response and reduced inflammation lead to a significant acceleration of healing.
###end p 51
###begin p 52
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 536 537 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 1211 1212 1211 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1340 1341 1340 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1348 1350 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 1633 1635 1633 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1637 1639 1637 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 1844 1846 1844 1846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 2009 2011 2009 2011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 2112 2114 2112 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 2155 2160 2155 2160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 2219 2220 2219 2220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2225 2226 2225 2226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2288 2289 2288 2289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2294 2295 2294 2295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1205 1209 <span type="species:ncbi:10090">mice</span>
###xml 1402 1410 <span type="species:ncbi:9606">patients</span>
###xml 2106 2110 <span type="species:ncbi:10090">mice</span>
Previous attempts to improve healing in diabetic wounds have focused either on improving angiogenesis via direct activation and/or enhancing recruitment of EPCs, or reducing excessive inflammation, and have met with various degrees of success [24, 38-40]. Reduced angiogenesis in diabetic wounds has been attributed to reduced mobilization, function, and engraftment of EPCs into tissues [39, 41]. However, direct application of SDF-1/CXCL12 enhances mobilization of EPCs and improves healing, specifically enhancing recruitment of Cd34+ EPCs into the neovasculature of granulation tissue [39, 42]. In the current study we have shown that HOXA3 induces expression of MCP-1/Ccl2, a related member of the CxC/CC chemokine family that has previously been shown to directly recruit EPCs [43] and stimulate angiogenesis [44]. Although we did not detect any differences in VEGF expression itself, reduced VEGF signaling, as well as aberrant cell adhesion properties of EPCs to endothelial cells in diabetic wounds, also contributes to poor EPC recruitment and retention [45-47]. VEGF itself has been shown sufficient for recruitment and retention of recruited bone marrow-derived circulating cells in wild type mice [5]. VEGF can accelerate wound healing when topically applied to diabetic wounds by promoting angiogenesis and recruitment of Tie2+ EPCs [47]. However, VEGF and other growth factor therapy in patients has proven less successful than expected, most likely due to high levels of proteases and advanced glycation end products (AGEs), both of which are associated with excessive inflammation in the diabetic wound environment [16, 48]. High levels of glucose can react nonenzymatically with the amino groups of proteins (glycation). One consequence of this is reduced effectiveness of downstream components of the VEGF signaling pathway [49]. Thus, treatment of damaged tissue, even with high levels of ligand, is ineffective. Furthermore, AGE-modified fibronectin significantly reduced EPC attachment [50], whereas blockade of the receptor for AGE significantly improved vascularization in diabetic mice [16]. Our findings that peripheral blood of HOXA3-treated animals contained greater numbers of immature Cd34+Cd133+ EPCs, whereas wounds contained predominantly more mature Cd34+Cd133- EPCs, suggest that HOXA3 not only increased mobilization of immature EPCs but also created an appropriate wound environment that was permissive to adhesion and subsequent maturation of the recruited EPCs. This environment may have also stimulated additional stem/progenitor cells not derived from the bone marrow, and thus not detectable by our GFP tracking methods, as these studies are based on cells derived from reconstituted bone marrow cells descended from hematopoietic stem cells.
###end p 52
###begin p 53
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pu.1</italic>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 779 781 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 1033 1042 1025 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf-&#945;</italic>
###xml 1098 1099 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1145 1150 1133 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 1155 1162 1143 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tollip,</italic>
###xml 1443 1448 1423 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myd88</italic>
###xml 1531 1533 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 1788 1790 1760 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
###xml 1807 1809 1779 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
Chronic wounds also exhibit high levels of proteases that can modify the provisional extracellular matrix necessary for proper EPC adhesion [51, 52]. The high levels of proteases present in diabetic and chronic wounds have been linked to excessive inflammation with recruited neutrophils and macrophages expressing high levels of a variety of matrix-degrading proteins [15]. A role for limiting inflammation in improving tissue repair is also supported by studies in Pu.1-null mice that lack neutrophils and macrophages. These mice healed faster and displayed no evidence of fibrosis compared with their wild type counterparts [14]. Importantly, in diabetic wounds, neutralization of TNF-alpha activity resulted in improved repair and healing due to inactivation of macrophages [40], and our present results show that in addition to improving EPC recruitment, HOXA3 also attenuates the TNF pathway, reducing inflammation. Specifically we show that HOXA3 inhibits hyperactivation of the NF-kappaB pathway, resulting in attenuation of Tnf-alpha expression, and leading to an overall reduction in Cd45+ leukocytes within the diabetic wound tissue. Myd88 and Tollip, both significantly downregulated by HOXA3 treatment, encode central components of the NF-kappaB pathway, functioning as adaptor proteins required for most Toll-like receptor activation of NF-kappaB in both wound-resident cells and recruited BMDCs. Interestingly, complete loss of Myd88 function, however, results in impaired wound healing and poor neovascularization [53]. Thus it seems that the correct balance of NF-kappaB activation must be achieved for efficient repair and regeneration. Concentration-dependent differential gene regulation by activated NF-kappaB is well documented (reviewed in Stathopoulos and Levine [54] and Sur et al [55]). We speculate that high levels of nuclear NF-kappaB result in transcription of genes promoting recruitment/retention of leukocytes, whereas moderate levels of nuclear NF-kappaB do not, thus facilitating healing.
###end p 53
###begin title 54
Differential Recruitment of EPCs and Leukocytes?
###end title 54
###begin p 55
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
###xml 611 616 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA3</italic>
###xml 1265 1267 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">57</xref>
###xml 1459 1461 1451 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58">58</xref>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
The majority of EPCs as well as inflammatory cells recruited to the wound are derived form stem/progenitor populations within the bone marrow. However, it is not clear how different populations within the bone marrow are differentially mobilized. For example, MCP-1/Ccl2 can mobilize EPCs and monocyte populations. Although application of this factor has been linked to improved repair and increased EPC recruitment, Ccl2-null mice also displayed reduced inflammation and skin fibrosis after wounding [56]. Thus the precise mechanisms that allow for enhanced EPC recruitment but restrict leukocyte retention in HOXA3-treated wounds are not clear. Whether enhanced EPC recruitment accelerates vascular maturation and stability, which in turn would reduce leukocyte extravasation, is not known. One possibility is that attenuated NF-kappaB activity results in a switch in phenotype of the recruited monocytes, resulting in their differentiation into endothelial cells or endothelial support cells instead of activated macrophages. This idea is supported by studies demonstrating that hematopoietic progenitor cell differentiation into an activated dendritic cell can be blocked by VEGF receptor activation on the progenitor cell and requires inhibition of NF-kappaB [57]. Furthermore, environmental cues, such as continued proangiogenic stimulation by factors such as VEGF, promote the differentiation of monocytic progenitor cells into endothelial-like cells [58]. Future studies will be focused on elucidating the precise gene regulatory networks downstream of HOXA3 function controlling the recruitment and behavior of EPCs to sites of injury.
###end p 55
###begin title 56
SUMMARY
###end title 56
###begin p 57
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">59</xref>
This study indicates that the ability of HOXA3 to activate multiple linked pathways to improve angiogenesis and EPC recruitment, as well as suppressing inflammatory pathways that can inhibit repair and regeneration, comprises a truly successful therapy for diabetic chronic wounds. HOXA3 acts as a "master control" transcription factor that sits at the top of a large transcriptional regulatory network, and affects a variety of pathways that regulate these processes in a developmental context [59]. It is tempting to speculate that restoring expression of "master morphoregulatory factors" important during embryonic development may significantly contribute to tissue repair therapies in adults, and perhaps provide a key to unlocking the potential for true tissue regeneration.
###end p 57
###begin title 58
DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST
###end title 58
###begin p 59
The authors indicate no potential conflicts of interest.
###end p 59
###begin p 60
The authors thank Mark Anderson (UCSF Diabetes center) and Amarjit Dosanjh (SFGH Surgical Lab) for their technical guidance in generating bone marrow chimeras, Marty Bigos and Valerie Stepps (Gladstone Flow Core) for their help with flow cytometry, and Kristin Mooseman for technical assistance. We also thank Matt Ronshaugen for many helpful comments and hours of discussion. This work was supported by NIH grants F32DK071406 (K.A.M), R01GM068778 (D.M.Y.), and P01NS44155 (N.J.B.), and a Healing Foundation Fellowship award (K.A.M.). J. L. R. is currently affiliated with the Department of Pathology, Beth Israel Deaconess Medical Center, Massachusetts, USA.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin article-title 62
HIF-1alpha is essential for myeloid cell-mediated inflammation
###end article-title 62
###begin article-title 63
Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair
###end article-title 63
###begin article-title 64
HOXA3 induces cells migration in endothelial and epithelial cells promoting angiogenesis and wound repair
###end article-title 64
###begin article-title 65
SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells
###end article-title 65
###begin article-title 66
VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells
###end article-title 66
###begin article-title 67
Bone marrow-derived stem cells in wound healing: a review
###end article-title 67
###begin article-title 68
Biology of bone marrow-derived endothelial cell precursors
###end article-title 68
###begin article-title 69
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis
###end article-title 69
###begin article-title 70
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
###end article-title 70
###begin article-title 71
Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells
###end article-title 71
###begin article-title 72
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes
###end article-title 72
###begin article-title 73
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
###end article-title 73
###begin article-title 74
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Accelerated wound closure in neutrophil-depleted mice
###end article-title 74
###begin article-title 75
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Wound healing in the PU. 1 null mouse-tissue repair is not dependent on inflammatory cells
###end article-title 75
###begin article-title 76
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair
###end article-title 76
###begin article-title 77
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
###end article-title 77
###begin article-title 78
Hox genes in hematopoiesis and leukemogenesis
###end article-title 78
###begin article-title 79
Homeobox B3 promotes capillary morphogenesis and angiogenesis
###end article-title 79
###begin article-title 80
HoxD3 expression and collagen synthesis in diabetic fibroblasts
###end article-title 80
###begin article-title 81
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation
###end article-title 81
###begin article-title 82
WebGestalt: an integrated system for exploring gene sets in various biological contexts
###end article-title 82
###begin article-title 83
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
###end article-title 83
###begin article-title 84
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators
###end article-title 84
###begin article-title 85
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds
###end article-title 85
###begin article-title 86
###xml 114 121 <span type="species:ncbi:9606">patient</span>
Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient
###end article-title 86
###begin article-title 87
###xml 7 11 <span type="species:ncbi:10090">mice</span>
'Green mice' as a source of ubiquitous green cells
###end article-title 87
###begin article-title 88
In vitro differentiation of endothelial cells from AC133-positive progenitor cells
###end article-title 88
###begin article-title 89
###xml 47 52 <span type="species:ncbi:9606">human</span>
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
###end article-title 89
###begin article-title 90
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation
###end article-title 90
###begin article-title 91
Cell-cell signaling in the neurovascular unit
###end article-title 91
###begin article-title 92
Making sense of hypertrophic scar: a role for nerves
###end article-title 92
###begin article-title 93
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice
###end article-title 93
###begin article-title 94
Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells
###end article-title 94
###begin article-title 95
Regulation of the composition of the extracellular matrix by low density lipoprotein receptor-related protein-1: activities based on regulation of mRNA expression
###end article-title 95
###begin article-title 96
Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface
###end article-title 96
###begin article-title 97
Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor
###end article-title 97
###begin article-title 98
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds
###end article-title 98
###begin article-title 99
Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha
###end article-title 99
###begin article-title 100
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages
###end article-title 100
###begin article-title 101
Impaired integration of endothelial progenitor cells in capillaries of diabetic wounds is reversible with vascular endothelial growth factor infusion
###end article-title 101
###begin article-title 102
Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing
###end article-title 102
###begin article-title 103
Regulation of endothelial progenitor cell homing after arterial injury
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression
###end article-title 104
###begin article-title 105
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures
###end article-title 105
###begin article-title 106
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse
###end article-title 106
###begin article-title 107
Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells
###end article-title 107
###begin article-title 108
Growth factors and chronic wound healing: past, present, and future
###end article-title 108
###begin article-title 109
Advanced glycation: implications in tissue damage and disease
###end article-title 109
###begin article-title 110
Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy
###end article-title 110
###begin article-title 111
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Gelatinase activities in wounds of healing-impaired mice versus wounds of non-healing-impaired mice
###end article-title 111
###begin article-title 112
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients
###end article-title 112
###begin article-title 113
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors
###end article-title 113
###begin article-title 114
###xml 32 42 <span type="species:ncbi:7227">Drosophila</span>
Dorsal gradient networks in the Drosophila embryo
###end article-title 114
###begin article-title 115
The two-faced NF-kappaB in the skin
###end article-title 115
###begin article-title 116
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Diminished induction of skin fibrosis in mice with MCP-1 deficiency
###end article-title 116
###begin article-title 117
Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells
###end article-title 117
###begin article-title 118
###xml 20 25 <span type="species:ncbi:9606">human</span>
CD34- blood-derived human endothelial cell progenitors
###end article-title 118
###begin article-title 119
Hox3 genes coordinate mechanisms of genetic suppression and activation in the generation of branchial and somatic motoneurons
###end article-title 119
###begin title 120
Supplemental material
###end title 120

